Paliperidone Sandoz 9 mg prolonged-release tablets EFG

Package leaflet: Information for the user

Introduction

Package leaflet: information for the patient

Paliperidona Sandoz 3 mg prolonged-release tablets EFG

Paliperidona Sandoz 6 mg prolonged-release tablets EFG

Paliperidona Sandoz 9 mg prolonged-release tablets EFG

Read the entire leaflet carefully before you start taking this medicine, because it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any questions, consult your doctor or pharmacist.
• This medicine has been prescribed for you only, and you should not give it to others, even if they have the same symptoms as you, because it may harm them.
• If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. See section 4.

Leaflet contents

1. What Paliperidona Sandoz is and what it is used for
2. What you need to know before taking Paliperidona Sandoz
3. How to take Paliperidona Sandoz
4. Possible adverse effects
5. How to store Paliperidona Sandoz
6. Contents of the pack and other information

1. What Paliperidona Sandoz is and what it is used for

Paliperidona Sandoz contains the active substance paliperidona, which belongs to the class of medicines known as antipsychotics.

Paliperidone is used to treat schizophrenia in adults and adolescents aged 15 years and older.

Schizophrenia is a disorder that causes symptoms such as hearing, seeing, or feeling things that do not exist, having false beliefs, excessive mistrust, social withdrawal, incoherent speech, and blunted behavior and emotional expression. People with this disorder may also feel depressed, anxious, guilty, or tense.

Paliperidone is also used to treat schizoaffective disorder in adults.

Schizoaffective disorder is a mental condition in which a person experiences several of the symptoms of schizophrenia (listed in the paragraph above) as well as mood disorder symptoms (feelings of euphoria, sadness, agitation, distractibility, insomnia, pressured speech, loss of interest in daily activities, excessive or reduced sleep, excessive or reduced food intake, and recurrent thoughts of suicide).

Paliperidone may help relieve the symptoms of your illness and prevent them from returning.

2. What you need to know before taking Paliperidona Sandoz

Do not take Paliperidona Sandoz

• if you are allergic to paliperidone, risperidone, or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor, pharmacist, or nurse before starting to take paliperidone.

• Patients with schizoaffective disorder treated with this medicine must be closely monitored due to a potential shift from manic to depressive symptoms.
• This medicine has not been studied in elderly patients with dementia. However, elderly patients with dementia who are treated with other similar medicines may have an increased risk of stroke or death (see section 4, Possible side effects).
• If you have Parkinson's disease or dementia.
• If you have ever been diagnosed with a condition characterized by high temperature and muscle rigidity (also known as Neuroleptic Malignant Syndrome).
• If you have ever experienced abnormal movements of the tongue or face (Tardive Dyskinesia).

You should be aware that these two disorders may be caused by this type of medicine.

• If you have previously had low levels of white blood cells in your blood (whether or not caused by other medicines).
• If you have diabetes or are prone to diabetes.
• If you have heart disease or are being treated for heart conditions that may make you more susceptible to low blood pressure.
• If you have epilepsy.
• If you have swallowing difficulties, or stomach or intestinal problems that reduce your ability to swallow food or digest it with normal intestinal movements.
• If you have conditions associated with diarrhea.
• If you have kidney problems.
• If you have liver problems.
• If you experience prolonged and/or painful erection.
• If you have difficulty regulating body temperature or are overheated.
• If you have abnormally high levels of the hormone prolactin in your blood or if you have a tumor that may be prolactin-dependent.
• If you or someone in your family has a history of blood clots, as antipsychotics have been associated with blood clot formation.

If you have any of these conditions, please consult your doctor, as a dose adjustment or monitoring may be necessary.

Because, very rarely, patients treated with paliperidone have developed a dangerously low number of a type of white blood cell essential for fighting infections, your doctor may check your white blood cell count.

Paliperidone may cause weight gain. Significant weight gain can negatively affect your health. Your doctor will regularly monitor your weight.

Cases of diabetes mellitus or worsening of pre-existing diabetes mellitus have been observed in patients treated with paliperidone. Your doctor should check for signs of elevated blood sugar. In patients with pre-existing diabetes mellitus, blood sugar levels should be monitored regularly.

During cataract surgery (clouding of the lens), the pupil (the black circle in the center of the eye) may not dilate as required. In addition, the iris (the colored part of the eye) may become floppy during surgery, which could cause eye damage. If you are considering eye surgery, make sure to inform your ophthalmologist that you are taking this medicine.

Children and adolescents

Paliperidona must not be given to children and adolescents under 15 years of age for the treatment of schizophrenia.

Paliperidona must not be given to children and adolescents under 18 years of age for the treatment of schizoaffective disorder.

This is because it is unknown whether paliperidone is safe or effective in this age group.

Other medicines and Paliperidona Sandoz

Tell your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.

Abnormalities in the heart's electrical function may occur when this medicine is taken together with other medicines used to control heart rhythm or other medicines such as antihistamines, antimalarials, or antipsychotics.

Since this medicine acts mainly on the brain, it may interact with other medicines (or alcohol) that also act on the brain, due to additive effects on brain function.

This medicine may lower blood pressure, so caution is advised if you take it together with other medicines that also lower blood pressure.

This medicine may reduce the effect of medicines used for Parkinson's disease and restless legs syndrome (e.g., levodopa).

The effects of this medicine may be altered if you take medicines that affect intestinal motility (e.g., metoclopramide).

Dose reduction of this medicine should be considered when administered concomitantly with valproate.

The use of oral risperidone together with this medicine is not recommended, as this combination may lead to an increase in adverse effects.

Paliperidone should be used with caution with medicines that increase central nervous system activity (psychostimulants such as methylphenidate).

Taking Paliperidona Sandoz with alcohol

You should avoid alcohol consumption during treatment with this medicine.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before taking this medicine.

You must not take this medicine during pregnancy unless you have discussed it with your doctor.

The following symptoms may occur in newborn babies of mothers who have been treated with paliperidone during the last trimester of pregnancy (last three months of pregnancy): tremors, muscle stiffness and/or weakness, drowsiness, agitation, breathing difficulties, and feeding problems. If your baby develops any of these symptoms, contact your doctor.

You must not breastfeed while taking this medicine.

Driving and using machines

During treatment with this medicine, dizziness and vision problems may occur (see section 4, Possible side effects). This should be taken into account when maximum attention is required, e.g., when driving or operating machinery.

Paliperidona Sandoz contains sodium

This medicine contains 15.74 mg of sodium (main component of table/cooking salt) in each prolonged-release tablet. This corresponds to 0.79% of the maximum daily recommended sodium intake for an adult.

3. How to take Paliperidona Sandoz

Follow exactly the instructions for administration of this medicine as given by your doctor, pharmacist, or nurse.

Use in adults

The recommended dose in adults is 6 mg once daily in the morning. Your doctor may increase or decrease it within the dose range of 3 mg to 12 mg once daily in the case of schizophrenia, or 6 mg to 12 mg once daily in the case of schizoaffective disorder. This depends on how well the medicine works for you.

Use in adolescents

The recommended starting dose for the treatment of schizophrenia in adolescents aged 15 years and older is 3 mg once daily taken in the morning.

For adolescents weighing 51 kg or more, the dose may be increased within the range of 6 mg to 12 mg once daily.

For adolescents weighing less than 51 kg, the dose may be increased to 6 mg once daily.

Your doctor will decide how much to prescribe. The dose you receive depends on how well the medicine works for you.

How and when to take Paliperidona Sandoz

This medicine should be taken orally, swallowed whole with water or other liquids. It must not be chewed, broken, or crushed.

This medicine should be taken in the morning with breakfast or on an empty stomach, but always in the same way every day. Do not alternate between taking the medicine one day with breakfast and the next day on an empty stomach.

The active substance, paliperidona, dissolves after swallowing, and the tablet coating is eliminated from the body through the faeces.

Patients with kidney problems

Your doctor may adjust the dose of this medicine according to your renal function.

Elderly patients

Your doctor may reduce your dose if you have reduced renal function.

If you take more Paliperidona Sandoz than you should

In case of overdose or accidental ingestion, contact your doctor or pharmacist immediately or call the Toxicology Information Service at: 91 562 04 20, indicating the medicine and the amount ingested.

You may experience drowsiness, fatigue, abnormal body movements, difficulty standing or walking, dizziness due to reduced blood pressure, and changes in heart rhythm.

If you forget to take Paliperidona Sandoz

Do not take a double dose to make up for forgotten doses. If you miss a dose, take the next dose the following day. If you miss two or more doses, contact your doctor.

If you stop taking Paliperidona Sandoz

Do not stop taking this medicine, as you will lose its beneficial effects. You should not discontinue this medicine unless instructed by your doctor, as symptoms may return.

If you have any further questions about the use of this medicine, ask your doctor, pharmacist, or nurse.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.

Contact your doctor immediately if:

• You develop blood clots in the veins, especially in the legs (symptoms include swelling, pain, and redness in the leg), which may travel through blood vessels to the lungs causing chest pain and difficulty breathing. If you notice any of these symptoms, seek medical advice immediately.
• You have dementia and experience a sudden change in your mental state, or sudden weakness or numbness of the face, arms, or legs—especially on one side—or have difficulty speaking, even for a short period. These may be signs of a stroke.
• You develop a high fever, muscle stiffness, sweating, or a reduced level of consciousness (a condition known as "Neuroleptic Malignant Syndrome"). Immediate medical treatment may be required.
• You are a man and have a prolonged or painful erection. This is known as priapism. Immediate medical treatment may be needed.
• You experience involuntary rhythmic movements of the tongue, mouth, or face. Discontinuation of paliperidone may be necessary.
• You have a severe allergic reaction characterized by fever, swelling of the mouth, face, lips, or tongue, difficulty breathing, itching, skin rash, and sometimes a drop in blood pressure (i.e., an "anaphylactic reaction").

Very common adverse effects: may affect more than 1 in 10 patients

• Difficulty falling or staying asleep,
• Parkinsonism: This condition may include slow or altered movement, a feeling of muscle stiffness or tightness (causing jerky movements), and sometimes a sensation of "freezing" in movement that then restarts. Other signs of parkinsonism include slow shuffling gait, resting tremor, increased saliva and/or drooling, and reduced facial expressiveness,
• Restlessness,
• Feeling drowsy or less alert/awake,
• Headache.

Common adverse effects: may affect up to 1 in 10 patients

• Chest infection (bronchitis), symptoms of a common cold, nasal infection, urinary tract infection, feeling as if you have the flu,
• Weight gain, increased appetite, weight loss, decreased appetite,
• Euphoria (mania), irritability, depression, anxiety,
• Dystonia: A condition involving involuntary, slow, or sustained muscle contractions. Although any part of the body may be affected (and may lead to abnormal postures), dystonia frequently affects facial muscles, including abnormal eye, mouth, tongue, or jaw movements,
• Dizziness,
• Dyskinesia: A condition involving involuntary muscle movements, which may include repetitive, spasmodic, or twisting movements or spasms,
• Tremor,
• Blurred vision,
• Conduction block between the upper and lower chambers of the heart, abnormalities in the heart's electrical conduction, QT interval prolongation in the heart, slow heartbeat, fast heartbeat,
• Drop in blood pressure upon standing (as a result, some people taking paliperidone may feel weak, dizzy, or faint when standing up or sitting up suddenly), increased blood pressure,
• Sore throat, cough, nasal congestion,
• Abdominal pain or discomfort, vomiting, nausea, constipation, diarrhea, indigestion, dry mouth, toothache,
• Increased liver transaminases in blood,
• Itching, skin rash,
• Bone or muscle pain, back pain, joint pain,
• Absence of menstrual periods,
• Fever, weakness, fatigue (tiredness).

Uncommon adverse effects: may affect up to 1 in 100 patients

• Pneumonia, respiratory tract infection, bladder infection, ear infection, tonsillitis,
• Decreased number of white blood cells, decreased platelets (blood cells that help stop bleeding), anemia, decreased number of red blood cells,
• Paliperidone may increase levels of a hormone called "prolactin" detectable in blood tests (this may or may not cause symptoms). When symptoms of elevated prolactin occur, they may include: (in men) breast swelling, difficulty achieving or maintaining erections, or other sexual dysfunction; (in women) breast discomfort, milk secretion from the breasts, absence of menstrual periods, or other menstrual cycle problems,
• Diabetes or worsening of diabetes, increased blood sugar, increased waist circumference, loss of appetite leading to malnutrition and reduced body weight, increased blood triglycerides (a type of fat),
• Sleep disorder, confusion, decreased sexual desire, inability to achieve orgasm, nervousness, nightmares,
• Tardive dyskinesia (uncontrollable spasms or spasmodic movements of the face, tongue, or other body parts). Inform your doctor immediately if you experience involuntary rhythmic movements of the tongue, mouth, or face. Discontinuation of paliperidone may be necessary,
• Seizures (epileptic fits), fainting, restlessness causing movement of body parts, dizziness upon standing, attention disturbance, speech problems, loss or changes in taste, reduced skin sensitivity to pain or touch, tingling, prickling, or numbness of the skin,
• Light sensitivity of the eyes, eye infection, or "red eye", dry eyes,
• Sensation of spinning (vertigo), ringing in the ears, ear pain,
• Irregular heartbeat, abnormal electrical activity of the heart (electrocardiogram or ECG), fluttering or pounding sensation in the chest (palpitations),
• Decreased blood pressure,
• Difficulty breathing, wheezing (whistling in the chest), nosebleeds,
• Tongue swelling, stomach or intestinal infection, difficulty swallowing, excess gas or flatulence,
• Increased GGT (a liver enzyme called gamma-glutamyl transferase) in blood, increased liver enzymes in blood,
• Hives (or "urticaria"), hair loss, eczema, acne,
• Increased CPK (creatine phosphokinase) in blood, a muscle enzyme sometimes released during muscle breakdown, muscle spasms, joint stiffness, joint swelling, muscle weakness, neck pain,
• Urinary incontinence (loss of bladder control), frequent urination, inability to pass urine, painful urination,
• Erectile dysfunction, ejaculation disorder,
• Absence of menstrual periods or other cycle problems (women), milk secretion from the breasts,
• Breast discomfort, sexual dysfunction, breast pain, breast discomfort,
• Swelling of the face, mouth, eyes, or lips, body swelling, arms or legs swelling,
• Chills, increased body temperature,
• Change in walking pattern,
• Feeling of thirst,
• Chest pain, chest discomfort, feeling unwell,
• Falls.

Rare adverse effects: may affect up to 1 in 1,000 patients

• Eye infection, fungal nail infection, skin infection, skin inflammation caused by mites,
• Dangerously low number of a type of white blood cells needed to fight infections,
• Decreased number of a type of white blood cells that help fight infections, increased eosinophils (a type of white blood cell) in blood,
• Severe allergic reaction characterized by fever, swelling of the mouth, face, lips, or tongue, breathing difficulty, itching, skin rash, and sometimes drop in blood pressure, allergic reaction,
• Sugar in urine,
• Inappropriate secretion of a hormone that controls urine volume,
• Life-threatening complications of uncontrolled diabetes,
• Dangerously excessive water intake, low blood sugar, excessive water intake, increased blood cholesterol,
• Sleepwalking,
• Lack of movement or response while awake (catatonia),
• Absence of emotions,
• Neuroleptic Malignant Syndrome (confusion, reduced or lost consciousness, high fever, and severe muscle rigidity),
• Loss of consciousness, balance disorder, abnormal coordination,
• Problems in brain blood vessels, coma due to uncontrolled diabetes, unresponsiveness to stimuli, reduced level of consciousness, head tremor,
• Glaucoma (increased pressure in the eyeball), increased tearing, eye redness, eye movement problems, eye rolling,
• Atrial fibrillation (abnormal heart rhythm), fast heartbeat upon standing,
• Blood clots in the veins, especially in the legs (symptoms include leg swelling, pain, and redness), which may travel through blood vessels to the lungs causing chest pain and breathing difficulty. If you experience any of these symptoms, seek medical help immediately,
• Reduced oxygen in body parts (due to reduced blood flow), flushing,
• Breathing problems during sleep (sleep apnea), rapid, shallow breathing,
• Pneumonia caused by aspiration of food, respiratory congestion, voice disorder,
• Intestinal obstruction, fecal incontinence, very hard stools, absence of intestinal movement leading to obstruction,
• Yellowing of the skin and eyes (jaundice),
• Pancreatitis (inflammation of the pancreas),
• Severe allergic reaction with swelling, which may affect the throat causing breathing difficulty,
• Skin thickening, dry skin, skin redness, skin discoloration, scaly and itchy skin or scalp, dandruff,
• Muscle fiber breakdown and muscle pain (rhabdomyolysis), postural abnormality,
• Priapism (a prolonged erection that may require surgical treatment),
• Breast development in men, enlarged mammary glands, milk secretion from breasts, vaginal secretion,
• Delayed menstrual periods, breast enlargement,
• Very low body temperature, decreased body temperature,
• Medication withdrawal symptoms.

Adverse effects with unknown frequency: cannot be estimated from available data

• Lung congestion,
• Increased insulin (a hormone that controls blood sugar levels) in blood.

The following adverse effects have been reported with the use of another medicine called risperidone, which is very similar to paliperidone; therefore, they are also expected to occur with paliperidone: sleep-related eating disorder, other types of brain blood vessel problems, crackling lung sounds, and severe or life-threatening skin rash with blisters and peeling skin that may start around the mouth, nose, eyes, genitals, and spread to other body areas (Stevens-Johnson Syndrome or toxic epidermal necrolysis). Eye problems may also occur during cataract surgery. During cataract surgery, a condition called intraoperative floppy iris syndrome (IFIS) may occur if you are taking or have taken paliperidone. If you need cataract surgery, make sure to inform your ophthalmologist if you are taking or have taken this medicine.

Additional adverse effects in adolescents

Adolescents generally experienced adverse effects similar to those seen in adults, except for the following effects, which occurred more frequently:

• Feeling drowsy or less alert/awake,
• Parkinsonism: This condition may include slow or altered movement, a feeling of muscle stiffness or tightness (causing jerky movements), and sometimes a sensation of "freezing" in movement that then restarts. Other signs of parkinsonism include slow shuffling gait, resting tremor, increased saliva and/or drooling, and reduced facial expressiveness,
• Weight gain,
• Common cold symptoms,
• Restlessness,
• Tremor,
• Stomach pain,
• Milk secretion from the breasts in girls,
• Breast swelling in boys,
• Acne,
• Speech problems,
• Stomach or intestinal infection,
• Nosebleeds,
• Ear infection,
• High blood triglycerides (a type of fat),
• Sensation of movement (vertigo).

Reporting of adverse effects

If you experience any adverse effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report them directly via the Spanish Pharmacovigilance System for Human Medicines: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Paliperidone Sandoz

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the blister and the carton after EXP/CAD. The expiry date refers to the last day of the month indicated.

Store in the original packaging to protect from moisture.

Medicines should not be disposed of via wastewater or household waste. Dispose of unused medicines and their packaging at the SIGRE collection point at your pharmacy. If you are in doubt, please ask your pharmacist how to dispose of medicines and packaging you no longer need. This will help protect the environment.

6. Contents of the pack and other information

Composition of Paliperidona Sandoz

• The active substance is paliperidone.

Paliperidona Sandoz 3 mg prolonged-release tablets.

Each tablet contains 3 mg of paliperidone.

Paliperidona Sandoz 6 mg prolonged-release tablets.

Each tablet contains 6 mg of paliperidone.

Paliperidona Sandoz 9 mg prolonged-release tablets.

Each tablet contains 9 mg of paliperidone.

• The other components are:

Tablet core

Macrogol 200000
Macrogol 7000000
Butylhydroxytoluene (E 321)
Povidone K30
Sodium chloride
Microcrystalline cellulose
Magnesium stearate
Red iron oxide (E 172)
Hydroxypropyl cellulose

Coating

(3 mg, 6 mg, 9 mg)

Cellulose acetate
Polyethylene glycol 4000
Hypromellose 6 cP
Titanium dioxide (E 171)
Talc
Propylene glycol

(6 mg)

Yellow iron oxide (E 172)

(9 mg)

Red iron oxide (E 172)

Printing ink

Lacquer
Black iron oxide (E 172)
Propylene glycol

Appearance of the product and contents of the pack

Paliperidona Sandoz 3 mg are prolonged-release tablets, white to off-white, round, biconvex, possibly with an irregular surface, marked with "P3" on one side.

Paliperidona Sandoz 6 mg are prolonged-release tablets, brownish-yellow, round, biconvex, possibly with an irregular surface, marked with "P6" on one side.

Paliperidona Sandoz 9 mg are prolonged-release tablets, pink, round, biconvex, possibly with an irregular surface, marked with "P9" on one side.

The prolonged-release tablets are packaged in unit dose blisters made of OPA/AL/PVC/Aluminum and contained in a cardboard carton.

Pack sizes: 14x1, 28x1, 30x1, 49x1, 56x1 and 98x1 prolonged-release tablets.

Only certain pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

Sandoz Farmacéutica, S.A.
Parque Norte Business Centre
Roble Building
C/ Serrano Galvache, 56
28033 Madrid
Spain

Manufacturer

KRKA, d.d., Novo mesto
Šmarješka cesta 6
8501 Novo mesto
Slovenia

or

Lek Pharmaceuticals d.d.
Verovškova 57
SLO-1526 Ljubljana
Slovenia

Date of latest revision of the package leaflet: March 2024

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency of Medicines and Health Products (AEMPS) http://www.aemps.gob.es/